SAN ANTONIO, Sept. 21, 2012 /PRNewswire/ -- The "Youth Pill" presentation won't happen until 6:00 p.m. this evening in the exhibit hall of the San Antonio Convention Center, but the Obesity Society's exclusive 30th Annual Meeting is buzzing with the same level of excitement normally reserved for a rock concert. Attendees at the conference — some of the world's most prestigious scientists — are eagerly awaiting the results of a research study conducted on an oral pill, in fact a dietary supplement called SeroVital™-hgh, developed by Sierra Research Group LLC, which may be capable of increasing serum (blood) growth hormone levels.
Some of the most cutting-edge obesity research in the world is being presented at this conference, so why is this particular presentation causing such a stir? Because HGH — which has been used for years by athletes seeking a competitive edge — has now gone mainstream as women and popular media outlets such as Dr. Oz, the Today Show, Fox News, CNN, Shape magazine, Vanity Fair, etc. have started discovering its touted benefits like reducing body fat, increasing lean muscle mass, boosting mood, strengthening bones, heightening sex drive, giving you plenty of energy and getting rid of wrinkles… making you look and feel decades — not years, but decades — younger.
For years, the only proven way to increase your growth hormone levels was through expensive prescription injections. But that may all be changing when tonight's research results are revealed. Those attending the conference realize that if there truly is an oral compound that can match the metabolic parameters of synthetic HGH injections, both the anti-aging and weight-loss industries could be completely revolutionized.
The presentation will take place this evening (Friday, September 21, 2012) from 6:00-7:30 p.m. in the Exhibit Hall of the San Antonio Convention Center.
To learn more contact Ariel Dunne at Behrman Communications: 212-986-7000 or email@example.com
©2012 All Rights Reserved
|SOURCE Sierra Research Group LLC|
Copyright©2012 PR Newswire.
All rights reserved